RE: Winners and losers30 May 2024 22:42
Gelesis was a write off. The Ozempic and Wogovy drugs came along. I wouldn’t call Gelesis, Alkali or Vor jewels for Puretech. The focus should be on the four main areas in Gallop, Seaport, Vedanta and LYT-100 now and realising more value on them.